XTL Biopharmaceuticals (XTLB) Stock: Buy, Sell, or Hold?
XTLB - XTL Biopharmaceuticals Ltd. American Depositary Shares
$2.16
0.03 (1.41%)
▲
5d:
-1.82%
30d:
-12.55%
90d:
-20.88%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $2.16, which is considered oversold relative to its 30-day fair value range of $2.25 to $2.55.
Technical Outlook: Technically, XTLB is showing sideways momentum. The price is currently testing key support at $2.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XTLB scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1288.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XTLB is showing sideways momentum. The price is currently testing key support at $2.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XTLB scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+1288.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.25 -
$2.55
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1288.9% below Wall St target ($30.00)
- CAUTION: Bottoming setup, but lagging the sector by 27% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$2.25 -
$2.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$2.50
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$30.00
(+1288.9%)
Earnings Growth (YoY)
-76.0%
Share & Embed Analysis
Last updated: October 04, 2026 3:31 AM ET
Data refreshes hourly during market hours. Next update: 4:31 AM
Data refreshes hourly during market hours. Next update: 4:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 55 HOLD |